Amino Acids

, Volume 42, Issue 6, pp 2223–2232 | Cite as

Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production

  • Chian Ju Jong
  • Junichi Azuma
  • Stephen SchafferEmail author
Original Article


An important function of the β-amino acid, taurine, is the regulation of oxidative stress. However, taurine is neither a classical scavenger nor a regulator of the antioxidative defenses, leaving uncertain the mechanism underlying the antioxidant activity of taurine. In the present study, the taurine antagonist and taurine transport inhibitor, β-alanine, was used to examine the mechanism underlying the antioxidant activity of taurine. Exposure of isolated cardiomyocytes to medium containing β-alanine for a period of 48 h led to a 45% decrease in taurine content and an increase in mitochondrial oxidative stress, as evidenced by enhanced superoxide generation, the inactivation of the oxidant sensitive enzyme, aconitase, and the oxidation of glutathione. Associated with the increase in oxidative stress was a decline in electron transport activity, with the activities of respiratory chain complexes I and III declining 50–65% and oxygen consumption falling 30%. A reduction in respiratory chain activity coupled with an increase in oxidative stress is commonly caused by the development of a bottleneck in electron transport that leads to the diversion of electrons from the respiratory chain to the acceptor oxygen forming in the process superoxide. Because β-alanine exposure significantly reduces the levels of respiratory chain complex subunits, ND5 and ND6, the bottleneck in electron transport appears to be caused by impaired synthesis of key subunits of the electron transport chain complexes. Co-administration of taurine with β-alanine largely prevents the mitochondrial effects of β-alanine, but treatment of the cells with 5 mM taurine in the absence of β-alanine has no effect on the mitochondria, likely because taurine treatment has little effect on cellular taurine levels. Thus, taurine serves as a regulator of mitochondrial protein synthesis, thereby enhancing electron transport chain activity and protecting the mitochondria against excessive superoxide generation.


Taurine β-Alanine Mitochondrial protein synthesis Oxidative stress Electron transport 



The study was supported with a grant from the American Heart Association.


  1. Aruoma OI, Halliwell B, Hoey BM, Butler J (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256:251–255PubMedGoogle Scholar
  2. Bouckenooghe T, Remacle C, Reusens B (2006) Is taurine a functional nutrient? Curr Opin Coln Nutr Metab Care 9:728–733CrossRefGoogle Scholar
  3. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ (2003) Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278:36927–36931Google Scholar
  4. Eley DW, Lake N, ter Keurs HEDJ (1994) Taurine depletion and excitation-contraction coupling in rat myocardium. Circ Res 74:11210–11219Google Scholar
  5. Gaull GE (1986) Taurine as a conditionally essential nutrient in man. J Am Coll Nutr 5:121–125PubMedGoogle Scholar
  6. Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer SW (2003) Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol 285:H2364–H2372Google Scholar
  7. Halestrap AP, Clarke SJ, Khalilin I (2007) The mitochondrial permeability transition pore—from molecular mechanism to reperfusion injury. In: Schaffer SW, Suleiman MS (eds) Mitochondria: the dynamic organelle. Springer Science + Business Media, New York, pp 241–269Google Scholar
  8. Harada H, Cusack BJ, Olson RD, Stroo W, Azuma J, Hamaguchi T, Schaffer SW (1980) Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pump. Biochem Pharm 39:745–751CrossRefGoogle Scholar
  9. Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haeussinger D (2002) Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16:231–233PubMedGoogle Scholar
  10. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163PubMedGoogle Scholar
  11. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to a cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937PubMedCrossRefGoogle Scholar
  12. Jong CJ, Ito T, Mozaffari M, Azuma J, Schaffer S (2010) Effect of β-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content. J Biomed Sci 17:S25PubMedCrossRefGoogle Scholar
  13. Kirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K, Suzuki T (2004) Codon-specific translational defect caused by wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci USA 101:15070–15075PubMedCrossRefGoogle Scholar
  14. Knopf K, Sturman JA, Armstrong M, Hayes KC (1978) Taurine: an essential nutrient for the cat. J Nutr 108:773–778PubMedGoogle Scholar
  15. Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–768PubMedCrossRefGoogle Scholar
  16. Ricci C, Pastukh V, Leonard J, Turrens J, Wilson G, Schaffer D, Schaffer SW (2008) Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol 294:C413–C422CrossRefGoogle Scholar
  17. Schaffer S, Solodushko V, Azuma J (2000) Taurine-deficient cardiomyopathy: role of phospholipids, calcium and osmotic stress. Adv Exp Med Biol 483:57–69PubMedCrossRefGoogle Scholar
  18. Schaffer SW, Solodushko V, Kakhniashvili D (2002) Beneficial effect of taurine depletion on osmotic sodium and calcium loading during chemical hypoxia. Am J Physiol 282:C1113–C1120Google Scholar
  19. Schaffer S, Azuma J, Takahashi K, Mozaffari M (2003a) Why is taurine cytoprotective? In: Lombardini JB, Schaffer SW, Azuma J (eds) Taurine 5. Kluwer Academic/Plenum Publishers, New York, pp 307–321Google Scholar
  20. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J (2003b) Possible cause of taurine deficient cardiomyopathy: potentiation of angiotensin II action. J Cardiovasc Pharmacol 41:751–759PubMedCrossRefGoogle Scholar
  21. Schaffer SW, Jong CJ, Ramila KC, Azuma J (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci (in press)Google Scholar
  22. Sturman JA (1993) Taurine in development. Physiol Rev 73:119–147PubMedGoogle Scholar
  23. Turrens JF (2007) Formation of reactive oxygen species in mitochondria. In: Schaffer SW, Suleiman M-S (eds) Mitochondria: the dynamic organelle. Springer Science + Business Media, New York, pp 185–196Google Scholar
  24. Wu JY, Prentice H (2010) Role of taurine in the central nervous system. J Biomed Sci 17(Suppl 1):S1PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Chian Ju Jong
    • 1
  • Junichi Azuma
    • 2
  • Stephen Schaffer
    • 1
    Email author
  1. 1.Department of Pharmacology, College of MedicineUniversity of South AlabamaMobileUSA
  2. 2.Department of Pharmacy, School of PharmacyHyogo University of Health SciencesKobeJapan

Personalised recommendations